Page last updated: 2024-08-16

temozolomide and dapagliflozin

temozolomide has been researched along with dapagliflozin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chinyama, HA; Huang, HS; Lawal, B; Mokgautsi, N; Wei, L; Wu, ATH	1

Other Studies

1 other study(ies) available for temozolomide and dapagliflozin

Article	Year
Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent. International journal of molecular sciences, 2023, Nov-16, Volume: 24, Issue:22 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; CDC2 Protein Kinase; Cell Line, Tumor; Checkpoint Kinase 1; Computational Biology; Drug Resistance, Neoplasm; Glioblastoma; Humans; Molecular Docking Simulation; Temozolomide	2023

Article

Year

Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent.

International journal of molecular sciences, 2023, Nov-16, Volume: 24, Issue:22

Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; CDC2 Protein Kinase; Cell Line, Tumor; Checkpoint Kinase 1; Computational Biology; Drug Resistance, Neoplasm; Glioblastoma; Humans; Molecular Docking Simulation; Temozolomide

2023